4th Quarter - Termination

OGR for ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED)

Firm
OGR
Client
Income
$50,000
Expenses
—
Terminated
Dec 31, 2022

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to Medicare coverage of health technologies and services; Medicare Coverage for Innovative Technology Rule; H.R.4043, Ensuring Patient Access to Critical Breakthrough Products Act of 2021; MDUFA Reauthorization; H.R.7667, Food and Drug Amendments of 2022, S.4348, FDASLA Act of 2022; H.R.2617, Consolidated Appropriations Act, 2023.

LobbyistCovered position, as disclosed
DEAN AGUILLEN —
MOSES MERCADO —
JEROME MURRAY —
KARISSA WILLHITE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2617 (117th), H.R. 4043 (117th), S. 4348 (117th), H.R. 7667 (117th)

Trade (domestic/foreign) TRD

Issues related to TRIPS Waiver.

LobbyistCovered position, as disclosed
DEAN AGUILLEN —
MOSES MERCADO —
JEROME MURRAY —
KARISSA WILLHITE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.